Chinese humanoid robot manufacturer Galbot has completed a new funding round of more than $300 million, lifting its total funding to approximately $800 million and pushing its valuation to around $3 billion. The investment places Galbot among the most highly valued companies in the global humanoid robotics sector, reflecting the rapid inflow of capital into embodied AI and general-purpose robotics.
The funding round attracted investors from China, Singapore, and the Middle East. While the company describes the round as record-setting within its segment, the valuation is best understood in the context of a broader surge of investment into humanoid robot developers worldwide, driven by expectations that advances in AI, perception, and manipulation will translate into scalable commercial systems.
Humanoid robots move toward commercial deployment
Over the past two years, humanoid robotics has shifted from research labs and staged demonstrations toward early operational use. Companies in China, the United States, and Europe are racing to develop platforms that can operate in human-designed environments, particularly in manufacturing, logistics, and service settings where labor shortages and flexibility demands are growing.
Galbot positions itself as a vertically integrated player, developing its own data pipelines, embodied AI models, and robotic hardware. According to the company, this approach is intended to shorten development cycles and support deployment across multiple application domains, rather than focusing on a single task or sector.
Focus on industrial and service environments
Galbot reports that its humanoid robots are already being used in pilot and early production settings across several industries. In manufacturing, the company says its robots are operating autonomously on factory floors in cooperation with major industrial firms. In logistics, Galbot points to warehouse deployments that have been running continuously for extended periods.
Beyond industrial environments, Galbot has also developed service-oriented applications. Its autonomous retail concept, branded as Galbot Store, uses humanoid robots to handle store operations without on-site staff. In healthcare, the company is working with hospitals to deploy robots for assistance tasks such as guidance, pharmacy support, and room services.
These deployments remain limited in scale compared to traditional industrial automation, but they illustrate the direction many humanoid developers are pursuing: proving reliability and economic value in tightly controlled, repetitive environments before attempting broader adoption.
Valuation reflects expectations, not maturity
A $3 billion valuation places Galbot in the top tier of humanoid robotics companies globally, alongside several well-funded peers pursuing similar general-purpose ambitions. As with much of the current humanoid market, the valuation reflects expectations of future impact rather than widespread, mature adoption.
Most humanoid systems today are still costly, complex to maintain, and limited in the range of tasks they can perform autonomously. Investors are betting that continued progress in embodied AI models, dexterous manipulation, and whole-body control will gradually reduce these barriers and open up large addressable markets.
A crowded and fast-moving field
Galbot’s funding round underscores how competitive the humanoid robotics landscape has become, particularly in China, where strong industrial demand and state-backed investment ecosystems are accelerating development. At the same time, companies in the US and Europe are pursuing parallel strategies, often targeting similar use cases in factories, warehouses, and service environments.
Whether Galbot’s valuation will be sustained will depend on its ability to scale deployments, control costs, and demonstrate consistent performance outside pilot projects. For now, the funding round serves as another signal that humanoid robotics has become a central focus of the global robotics investment cycle—no longer a speculative niche, but a sector investors expect to mature over the coming decade.
